227 related articles for article (PubMed ID: 24828664)
21. Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus.
Streppel MM; Lata S; DelaBastide M; Montgomery EA; Wang JS; Canto MI; Macgregor-Das AM; Pai S; Morsink FH; Offerhaus GJ; Antoniou E; Maitra A; McCombie WR
Oncogene; 2014 Jan; 33(3):347-57. PubMed ID: 23318448
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
Schulmann K; Sterian A; Berki A; Yin J; Sato F; Xu Y; Olaru A; Wang S; Mori Y; Deacu E; Hamilton J; Kan T; Krasna MJ; Beer DG; Pepe MS; Abraham JM; Feng Z; Schmiegel W; Greenwald BD; Meltzer SJ
Oncogene; 2005 Jun; 24(25):4138-48. PubMed ID: 15824739
[TBL] [Abstract][Full Text] [Related]
23. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
Li C; Cai J; Ge F; Wang G
Int J Mol Med; 2018 Oct; 42(4):1799-1808. PubMed ID: 30015899
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis.
Wang S; Zhan M; Yin J; Abraham JM; Mori Y; Sato F; Xu Y; Olaru A; Berki AT; Li H; Schulmann K; Kan T; Hamilton JP; Paun B; Yu MM; Jin Z; Cheng Y; Ito T; Mantzur C; Greenwald BD; Meltzer SJ
Oncogene; 2006 Jun; 25(23):3346-56. PubMed ID: 16449976
[TBL] [Abstract][Full Text] [Related]
25. MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.
Jin Z; Wang L; Zhang Y; Cheng Y; Gao Y; Feng X; Dong M; Cao Z; Chen S; Yu H; Zhao Z; Zhang X; Liu J; Mori Y; Fan X; Meltzer SJ
Sci Rep; 2013 Oct; 3():2838. PubMed ID: 24088706
[TBL] [Abstract][Full Text] [Related]
26. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
27. Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma.
Lin L; Bass AJ; Lockwood WW; Wang Z; Silvers AL; Thomas DG; Chang AC; Lin J; Orringer MB; Li W; Glover TW; Giordano TJ; Lam WL; Meyerson M; Beer DG
Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4251-6. PubMed ID: 22375031
[TBL] [Abstract][Full Text] [Related]
28. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
29. Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling.
Wang F; Wang L; Qu C; Chen L; Geng Y; Cheng C; Yu S; Wang D; Yang L; Meng Z; Chen Z
BMC Cancer; 2021 Apr; 21(1):396. PubMed ID: 33845796
[TBL] [Abstract][Full Text] [Related]
30. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy.
Abdel-Latif MM; O'Riordan J; Windle HJ; Carton E; Ravi N; Kelleher D; Reynolds JV
Ann Surg; 2004 Apr; 239(4):491-500. PubMed ID: 15024310
[TBL] [Abstract][Full Text] [Related]
31. TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.
Miyoshi N; Ishii H; Mimori K; Tanaka F; Hitora T; Tei M; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2010 Apr; 17(4):967-72. PubMed ID: 20033322
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference.
Zhou Z; Xia Y; Bandla S; Zakharov V; Wu S; Peters J; Godfrey TE; Sun J
Hum Pathol; 2014 Aug; 45(8):1744-51. PubMed ID: 24951052
[TBL] [Abstract][Full Text] [Related]
33. NcoI TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma.
Menke V; van Zoest KP; Moons LM; Hansen B; Pot RG; Siersema PD; Kusters JG; Kuipers EJ
Scand J Gastroenterol; 2012 Apr; 47(4):378-86. PubMed ID: 22243485
[TBL] [Abstract][Full Text] [Related]
34. IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma.
Myers AL; Lin L; Nancarrow DJ; Wang Z; Ferrer-Torres D; Thomas DG; Orringer MB; Lin J; Reddy RM; Beer DG; Chang AC
Oncotarget; 2015 Sep; 6(28):25897-916. PubMed ID: 26317790
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.
Gu J; Ajani JA; Hawk ET; Ye Y; Lee JH; Bhutani MS; Hofstetter WL; Swisher SG; Wang KK; Wu X
Cancer Prev Res (Phila); 2010 Sep; 3(9):1176-86. PubMed ID: 20651033
[TBL] [Abstract][Full Text] [Related]
36. Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.
Yu M; Maden SK; Stachler M; Kaz AM; Ayers J; Guo Y; Carter KT; Willbanks A; Heinzerling TJ; O'Leary RM; Xu X; Bass A; Chandar AK; Chak A; Elliott R; Willis JE; Markowitz SD; Grady WM
Gut; 2019 Mar; 68(3):389-399. PubMed ID: 29884612
[TBL] [Abstract][Full Text] [Related]
37. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression.
Hoang AT; Vizio B; Chiusa L; Cimino A; Solerio D; Do NH; Pileci S; Camandona M; Bellone G
Int J Med Sci; 2021; 18(6):1406-1414. PubMed ID: 33628097
[TBL] [Abstract][Full Text] [Related]
38. Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma.
Wu GD; Beer DG; Moore JH; Orringer MB; Appelman HD; Traber PG
Gastroenterology; 1993 Sep; 105(3):837-44. PubMed ID: 8359653
[TBL] [Abstract][Full Text] [Related]
39. LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation.
Whitsett TG; Mittal SK; Eschbacher JM; Carson VM; Smith MA; Bremner RM; Inge LJ
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1891-1899. PubMed ID: 29370903
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
